Research
Tissue and Liquid Biopsies May Complement Each Other in Prostate Cancer
The Brief
- An analysis of patients with metastatic castration-resistant prostate cancer was presented at the ESMO congress.
- The analysis found no statistically significant differences in actionable genomic alterations between the compared biopsy approaches.
- The headline suggests tissue and liquid biopsies may complement each other, but the sources provided only a partial summary.
Why it matters
Liquid biopsies are a less invasive way to look for actionable genomic alterations, so whether they can complement tissue biopsies matters for how advanced prostate cancer is profiled.
Who’s affected
- oncologists and clinicians treating prostate cancer
- prostate cancer researchers
- #prostate cancer
- #liquid biopsy
- #tissue biopsy
- #genomics
- #oncology
(MedPage Today) -- An analysis of patients with metastatic castration-resistant prostate cancer presented at the European Society for Medical Oncology (ESMO) congress found no statistically significant differences in actionable genomic alterations...